Foxconn To Build Hostels For 60,000 Employees In Tamil Nadu: Report

Foxconn makes Apple phones at its facility in Sriperumbudur where it employs over 15,000 workers, most of which are women

Foxconn said that the new quarters will have both food and medicine provided by the company. The same model is followed by Foxconn in China too.

Source : Getty

As Foxconn, the maker of iPhones, aims to boost the production of Apple devices in India, the company is reportedly building large hostels for nearly 60,000 employees at its manufacturing unit in Chennai, reported by the Economic Times (ET). According to the report, in response to the strong domestic demand for Apple products and Foxconn’s aim to diversify away from China, "brisk construction" is going on at a 20-acre plot in Tamil Nadu.

The Taiwanese firm makes Apple phones at its facility in Sriperumbudur where it employs over 15,000 workers, most of which are women. In the next 18 months, the number of employees is expected to go up to 70,000.

The first facility, which will be able to accommodate 20,000 people, will be ready in the next ten months, a person aware of the developments told ET. Apart from the hostels, the company is also constructing new manufacturing facilities inside its Sriperumbudur plant.

The new quarters will have both food and medicine provided by the company. The same model is followed by Foxconn in China too.

According to experts, this policy to construct housing facilities is "just an emulation of one part of a strategy that worked elsewhere".

In September, Apple began assembling iPhone 14 in India. In early December, Foxconn announced an infusion of $500 million into its India unit. The majority of the money would go towards boosting the production capacity, the company said in a regulatory filing.

Tamil Nadu is fast becoming the iPhone manufacturing hub in India, with Foxconn and Pegatron already housing their factories there. Wistron manufactures Apple devices at its Hosur facility in Karnataka.

Meanwhile, Foxconn is easing most of its anti-Covid curbs at its factory in Zhengzhou, China. This move is considered to be a significant step forward for the facility that had become a flashpoint in China’s efforts to contain infections.